Bone tissue and muscle dystrophin deficiency in mdx mice

Joint Bone Spine

Volumn 79, Issue 2, 2012, Pages 129-133

  Nakagaki, Wilson Romero ^a   Camilli, José Angelo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Bone; Dystrophin; Mdx mice; Muscular dystrophy

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; DYSTROPHIN; FIBROBLAST GROWTH FACTOR 2; OSTEOPONTIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; UTROPHIN; VASCULOTROPIN;

AGING; ANIMAL EXPERIMENT; BONE FRAGILITY; BONE METABOLISM; BONE TISSUE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE RELEASE; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHINOPATHY; GENE MUTATION; JOINT MOBILITY; LEUKOCYTE; MACROPHAGE; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE WEAKNESS; NONHUMAN; OSSIFICATION; OSTEOPENIA; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SHORT SURVEY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

AGING; ANIMALS; BONE AND BONES; BONE RESORPTION; DISEASE MODELS, ANIMAL; DYSTROPHIN; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 84857801450     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.08.004     Document Type: Short Survey

References (60)

1. Lovering R.M., Porter N.C., Bloch R.J. The muscular dystrophies: from genes to therapies. Phys Ther 2005, 85:1372-1388.
2. Blake D.J., Weir A., Newey S.E., et al. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
3. Petrof B.J. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 2002, 81:162-174.
4. Ervasti J.M. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 2007, 1772:108-117.
5. Durbeej M., Campbell K.P. Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 2002, 12:349-361.
6. Watchko J.F., O'Day T.L., Hoffman E.P. Functional characteristics of dystrophic skeletal muscle: insights from animal models. J Appl Physiol 2002, 93:407-417.
7. Ozawa E., Mizuno Y., Hagiwara Y., et al. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005, 32:563-576.
8. Jones K.J., Compton A.G., Yang N., et al. Deficiency of the syntrophins and alpha-dystrobrevin in patients with inherited myopathy. Neuromuscul Disord 2003, 13:456-467.
9. Rando T.A. Role of nitric oxide in the pathogenesis of muscular dystrophies: a " two hit" hypothesis of the cause of muscle necrosis. Microsc Res Tech 2001, 55:223-235.
10. Kaminski H.J., Andrade F.H. Nitric oxide: biologic effects on muscle and role in muscle diseases. Neuromuscul Disord 2001, 11:517-524.
11. Holterman C.E., Rudnicki M.A. Molecular regulation of satellite cell function. Semin Cell Dev Biol 2005, 16:575-584.
12. Allikian M.J., McNally E.M. Processing and assembly of the dystrophin glycoprotein complex. Traffic 2007, 8:177-183.
13. Salimena M.C., Lagrota-Candido J., Quírico-Santos T. Gender dimorphism influences extracellular matrix expression and regeneration of muscular tissue in mdx dystrophic mice. Histochem Cell Biol 2004, 122:435-444.
14. Biggar W.D. Duchenne muscular dystrophy. Pediatr Rev 2006, 27:83-88.
15. Bulfield G., Siller W.G., Wight P.A., et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984, 81:1189-1192.
16. Vainzof M., Ayub-Guerrieri D., Onofre P.C., et al. Animal models for genetic neuromuscular diseases. J Mol Neurosci 2008, 34:241-248.
17. Evans N.P., Misyak S.A., Robertson J.L., et al. Dysregulated intracellular signaling and inflammatory gene expression during initial disease onset in Duchenne muscular dystrophy. Am J Phys Med Rehabil 2009, 88:502-522.
18. McGeachie J.K., Grounds M.D., Partridge T.A., et al. Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies. J Neurol Sci 1993, 119:169-179.
19. Pastoret C., Sebille A. mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 1995, 129:97-105.
20. Porter J.D., Merriam A.P., Leahy P., et al. Dissection of temporal gene expression signatures of affected and spared muscle groups in dystrophin-deficient (mdx) mice. Hum Mol Genet 2003, 12:1813-1821.
21. Briguet A., Courdier-Fruh I., Foster M., et al. Histological parameters for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscul Disord 2004, 14:675-682.
22. Grounds M.D., Torrisi J. Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis. FASEB J 2004, 18:676-682.
23. Reed P., Bloch R.J. Postnatal changes in sarcolemmal organization in the mdx mouse. Neuromuscul Disord 2005, 15:552-561.
24. Minatel E., Neto H.S., Marques M.J. Acetylcholine receptor distribution and synapse elimination at the developing neuromuscular junction of mdx mice. Muscle Nerve 2003, 28:561-569.
25. Porter J.D., Merriam A.P., Khanna S., et al. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J 2003, 17:893-895.
26. Tanabe Y., Esaki K., Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 1986, 69:91-95.
27. Cullen M.J., Jaros E. Ultrastructure of the skeletal muscle in the X chromosome-linked dystrophic (mdx) mouse. Comparison with Duchenne muscular dystrophy. Acta Neuropathol 1988, 77:69-81.
28. Luz M., Marques M., Santo-Neto H. Impaired regeneration of dystrophin-deficient muscle fibers is causes by exhaustion of myogenic cells. Braz J Med Biol Res 2002, 35:691-695.
29. Lefaucheur J.P., Pastoret C., Sebille A. Phenotype of dystrophinopathy in old mdx mice. Anat Rec 1995, 242:70-76.
30. Deconinck A.E., Potter A.C., Tinsley J.M., et al. Postsynaptic abnormalities at the neuromuscular junctions of utrophin-deficient mice. J Cell Biol 1997, 136:883-894.
31. Jejurikar S.S., Kuzon W.M. Satellite cell depletion in degenerative skeletal muscle. Apoptosis 2003, 8:573-578.
32. Sacco A., Mourkioti F., Tran R., et al. Short telomeres and stem cell exhaustion model Duchenne muscular dystrophy in mdx/mTR mice. Cell 2010, 23:1059-1071.
33. Novotny S.A., Warren G.L., Lin A.S., et al. Bone is functionally impaired in dystrophic mice but less so than skeletal muscle. Neuromuscul Disord 2011, 21:183-193.
34. Hamrick M.W., Ding K.H., Pennington C., et al. Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone 2006, 39:845-853.
35. Kaneps A.J., Stover S.M., Lane N.E. Changes in canine cortical and cancellous bone mechanical properties following immobilization and remobilization with exercise. Bone 1997, 21:419-423.
36. Hart K.J., Shaw J.M., Vajda E., et al. Swim-trained rats have greater bone mass, density, strength, and dynamics. J Appl Physiol 2001, 91:1663-1668.
37. Renno A.C., Silveira Gomes A.R., Nascimento R.B., et al. Effects of a progressive loading exercise program on the bone and skeletal muscle properties of female osteopenic rats. Exp Gerontol 2007, 42:517-522.
38. McDonald D.G., Kinali M., Gallagher A.C., et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 2002, 44:695-698.
39. Bianchi M.L., Mazzanti A., Galbiati E., et al. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 2003, 14:761-767.
40. Sommerfeldt D.W., Rubin C.T. Biology of bone and how it orchestrates the form and function of the skeleton. Eur Spine J 2001, 10:86-95.
41. Hsu J.D. Skeletal changes in children with neuromuscular disorders. Factors and mechanisms influencing bone growth 1982, 553-557. Alan Liss, New York. 1st ed. A.D. Dixon, B.G. Sarnat (Eds.).
42. Palmieri G.M., Bertorini T.E., Griffin J.W., et al. Assessment of whole body composition with dual energy X-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function. Muscle Nerve 1996, 19:777-779.
43. Larson C.M., Henderson R.C. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000, 20:71-74.
44. Söderpalm A.C., Magnusson P., Ahlander A.C., et al. Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy. Neuromuscul Disord 2007, 17:919-928.
45. Anderson J.E., Lentz D.L., Johnson R.B. Recovery from disuse osteopenia coincident to restoration of muscle strength in mdx mice. Bone 1993, 14:625-634.
46. Aoyagi T., Wada T., Kojima F., et al. Various enzyme activities in muscle and other organs of dystrophic mice. J Clin Invest 1981, 67:51-59.
47. Nakagaki W.R., Bertran C.A., Matsumura C.Y., et al. Mechanical, biochemical and morphometric alterations in the femur of mdx mice. Bone 2011, 48:372-379.
48. Rufo A., Del Fattore A., Bianchi M.L., et al. Mechanisms inducing low bone density in Duchenne muscular dystrophy. Bone 2009, 44Suppl:237-238.
49. Montgomery E., Pennington C., Isales C.M., et al. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice. Anat Rec A Discov Mol Cell Evol Biol 2005, 286:814-822.
50. Straino S., Germani A., Di Carlo A., et al. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 2004, 110:3341-3348.
51. Spencer M.J., Tidball J.G. Do immune cells promote the pathology of dystrophin-deficient myopathies?. Neuromuscul Disord 2001, 11:556-564.
52. Vetrone S.A., Montecino-Rodriguez E., Kudryashova E., et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-β. J Clin Invest 2009, 119:1583-1594.
53. Burks T.N., Cohn R.D. Role of TGF-β signaling in inherited and acquired myopathies. Skeletal Muscle 2011, 1:19. 10.1186/2044-5040-1-19.
54. Ishitobi M., Haginoya K., Zhao Y., et al. Elevated plasma levels of transforming growth factor beta1 in patients with muscular dystrophy. Neuroreport 2000, 18:4033-4055.
55. Chenu C., Colucci S., Grano M., et al. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol 1994, 127:1149-1158.
56. Saadeh P.B., Mehrara B.J., Steinbrech D.S., et al. Transforming growth factor-beta1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 1999, 277:C628-C637.
57. Pang L., Wu X., Lei W., et al. IGF-I released during osteoclastic bone resorption induces osteoblast differentiation of BMSCs in the coupling process. J Bone Miner Res 2010, 25:S36.
58. Hamrick M.W., McNeil P.L., Patterson S.L. Role of muscle-derived growth factors in bone formation. J Musculoskelet Neuronal Interact 2010, 10:64-70.
59. Katagiri T., Yamaguchi A., Komaki M., et al. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J Cell Biol 1994, 127:1755-1766.
60. Lara N., Hall T., Touchberry C., et al. Bone-muscle crosstalk is demonstrated by morphological and functional changes in skeletal and cardiac muscle cells in response to factors produced by MLO-Y4 osteocytes. J Bone Miner Res 2010, 25:S112.